Form 4: Director Frist Acquires SEM Stock as Compensation
Insider Transaction Report
Select Medical Holdings Director William H. Frist acquired 1,266 shares of common stock as part of his quarterly retainer.
Summary
- Director William H. Frist acquired 1,266 shares of Select Medical Holdings Corporation common stock.
- The transaction occurred on October 28, 2025, at a price of $14.22 per share.
- This acquisition was a grant of restricted stock under the Select Medical Holdings Corporation 2020 Equity Incentive Plan.
- The shares were issued in lieu of a quarterly retainer of $18,000.
- Following this transaction, Mr. Frist beneficially owns 304,063 shares of common stock.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even as part of compensation, generally indicates confidence and aligns management interests with shareholders. It's a positive signal, though not a direct open-market purchase.
Positives
- Director William H. Frist increased his beneficial ownership in Select Medical Holdings Corporation by acquiring 1,266 shares.
- The acquisition was part of an equity incentive plan, aligning director interests with shareholders.
- The shares were granted in lieu of a cash retainer, indicating a preference for equity compensation.
Future Outlook
NA
Industry Context
This transaction reflects a common practice in the healthcare services industry where directors receive equity compensation to align their interests with long-term company performance. Select Medical Holdings operates in a sector focused on post-acute care and rehabilitation, where executive and director compensation structures often include equity components.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | William H. Frist granted John F. Duggan a Limited Power of Attorney for Section 16 reporting obligations, allowing him to prepare and file Forms 3, 4, and 5 on Frist's behalf. | 07/31/2025 | Streamlines compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate filings for the director. |
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholder value through equity compensation.
- Company: Utilizes equity as a form of compensation, potentially conserving cash.
Key Dates
| Date | Description |
|---|---|
| 07/31/2025 | Date William H. Frist executed the Limited Power of Attorney. |
| 10/28/2025 | Date of transaction where William H. Frist acquired common stock. |
| 10/30/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThis Form 4 reports a routine grant of restricted stock to a director as part of their compensation package, rather than an open-market purchase. While it indicates continued alignment of interests, it does not provide new fundamental information to warrant a change in investment thesis. The transaction is expected and does not suggest a significant shift in company prospects or valuation.
Keywords
Select Medical Holdings, SEM, William H. Frist, Insider Transaction, Form 4, Stock Acquisition, Director Compensation, Equity Incentive Plan, Healthcare Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.